OVERVIEW
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disease; however only 1 in 7 patients are diagnosed. Under-recognition of HCM and varied clinical presentation can cause diagnosis delays and misdiagnoses, thereby putting patients at greater risk of cardiovascular events. HCM is no longer a mystery. Evolving guideline recommendations have unlocked the potential for more timely diagnosis and advanced knowledge about pathogenesis has ushered in new and emerging therapeutic strategies with the opportunity to improve clinical outcomes for patients with HCM. In this symposium, expert faculty investigate a patient case from clinical presentation and diagnosis, to the latest advances in treatment of HCM. Can you help them crack the case?
GOAL STATEMENT
The goal of this activity is for learners to be better able to diagnose HCM and initiate guideline-directed, evidence-based treatment to optimize patient outcomes.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the[LIST][ITEM]Identification of the prevalence and consequences of HCM, including the implications of undiagnosed disease on patient outcomes[ITEM]Evaluation of current treatment options for HCM, including supporting clinical data and implications to address underlying mechanisms of disease[/LIST]Have greater competence related to[LIST][ITEM]Recognizing the signs and symptoms associated with HCM to raise disease suspicion[ITEM]Discussing the utility of echocardiography in the diagnostic workup of HCM[ITEM]Integrating appropriate treatment strategies in the personalized treatment of HCM[/LIST]Demonstrate greater confidence in their ability to[LIST][ITEM]Facilitate shared decision-making with patients to optimize HCM management[/LIST]
ACCREDITATION STATEMENT
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO] [MEDSCAPE]
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.5 [italic][bold]AMA PRA Category 1 Credits[/bold][/italic]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Westin Philadelphia
Georgian Ballroom
99 South 17th Street at Liberty Place
Philadelphia, Pennsylvania, 19103
United States
This event is not part of the official Scientific Sessions as planned by the AHA Committee on Scientific Sessions Programming.
Supported by an independent educational grant from [bold]Bristol-Myers Squibb[/bold].